Biden’s Drug Pricing Push, ChatGPT for Business, & Meta’s Disinformation Discovery 8/29/23

The Biden administration has unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. CNBC’s Bertha Coombs and Centers for Medicare and Medicaid Services Administrator, Chiquita Brooks-Lasure, discuss the announcement, how the list of drugs were chosen, and more. Amazon CEO Andy Jassy is reportedly ready to let go of remote employees who’d rather stay remote, and OpenAI is launching its chatbot business tier, called ChatGPT Enterprise. Plus, CNBC’s Eamon Javers reports, Meta says it has disrupted a disinformation campaign linked to Chinese law enforcement, what the platform has called the “largest known cross-platform covert influence operation in the world.”

Bertha Coombs 15:50

Chiquita Brooks-LaSure 20:33

Eamon Javers 28:17

In this episode:
Becky Quick, @BeckyQuick
Joe Kernen, @JoeSquawk
Eamon Javers, @EamonJavers
Chiquita Brooks-LaSure, @BrooksLaSureCMS
Bertha Coombs, @berthacoombs

Katie Kramer, @Kramer_Katie

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.